Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rika Nishimura

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cells|November 27, 2024
Differences in Uniquely Identified Peptides Between ddaPASEF and diaPASEFMio Iwasaki, Rika Nishimura, Tatsuya Yamakawa, et al.
Journal of Pharmacological Sciences|February 18, 2022
Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studiesTomoyoshi Miyamoto, Risa Domoto, Fumiko Sekiguchi, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cells|November 27, 2024
Differences in Uniquely Identified Peptides Between ddaPASEF and diaPASEFMio Iwasaki, Rika Nishimura, Tatsuya Yamakawa, et al.
Journal of Pharmacological Sciences|February 18, 2022
Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studiesTomoyoshi Miyamoto, Risa Domoto, Fumiko Sekiguchi, et al.
Pageof 1